- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x MN: MANGANESE (II) ION(Non-covalent)
- 4 x KU0: 2-[(2S)-1-(3,5-dichloropyridine-4-carbonyl)pyrrolidin-2-yl]-5-hydroxy-6-oxo-N-[2-(phenylsulfonyl)ethyl]-1,6-dihydropyrimidine-4-carboxamide(Non-covalent)
KU0.3: 14 residues within 4Å:- Chain A: Y.44, K.54, I.58, H.61, E.81, F.106, L.107, D.109, E.120, I.121, K.135, K.138
- Ligands: MN.1, MN.2
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:I.58, A:K.138
- Hydrogen bonds: A:Y.44, A:Y.44, A:K.54, A:K.135, A:K.135
- pi-Stacking: A:H.61, A:H.61
KU0.7: 14 residues within 4Å:- Chain B: Y.44, K.54, I.58, H.61, E.81, F.106, L.107, D.109, E.120, I.121, K.135, K.138
- Ligands: MN.5, MN.6
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:I.58, B:K.138
- Hydrogen bonds: B:Y.44, B:Y.44, B:K.54, B:K.135, B:K.135
- pi-Stacking: B:H.61, B:H.61
KU0.11: 14 residues within 4Å:- Chain C: Y.44, K.54, I.58, H.61, E.81, F.106, L.107, D.109, E.120, I.121, K.135, K.138
- Ligands: MN.9, MN.10
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:I.58, C:K.138
- Hydrogen bonds: C:Y.44, C:Y.44, C:K.54, C:K.135, C:K.135
- pi-Stacking: C:H.61, C:H.61
KU0.15: 14 residues within 4Å:- Chain D: Y.44, K.54, I.58, H.61, E.81, F.106, L.107, D.109, E.120, I.121, K.135, K.138
- Ligands: MN.13, MN.14
9 PLIP interactions:9 interactions with chain D- Hydrophobic interactions: D:I.58, D:K.138
- Hydrogen bonds: D:Y.44, D:Y.44, D:K.54, D:K.135, D:K.135
- pi-Stacking: D:H.61, D:H.61
- 4 x 9HD: 1-[(3R,5S,7R)-1,5,7,9-tetrakis(2-oxopyrrolidin-1-yl)nonan-3-yl]-1,3-dihydro-2H-pyrrol-2-one(Non-covalent)
9HD.4: 7 residues within 4Å:- Chain A: N.30, M.32, L.36, F.66, I.79, E.81, G.82
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:L.36, A:F.66, A:F.66, A:F.66, A:I.79
- Hydrogen bonds: A:N.30
9HD.8: 7 residues within 4Å:- Chain B: N.30, M.32, L.36, F.66, I.79, E.81, G.82
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:L.36, B:F.66, B:F.66, B:F.66, B:I.79
- Hydrogen bonds: B:N.30
9HD.12: 7 residues within 4Å:- Chain C: N.30, M.32, L.36, F.66, I.79, E.81, G.82
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:L.36, C:F.66, C:F.66, C:F.66, C:I.79
- Hydrogen bonds: C:N.30
9HD.16: 7 residues within 4Å:- Chain D: N.30, M.32, L.36, F.66, I.79, E.81, G.82
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:L.36, D:F.66, D:F.66, D:F.66, D:I.79
- Hydrogen bonds: D:N.30
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Beylkin, D. et al., Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus Endonuclease. Sci Rep (2017)
- Release Date
- 2018-02-07
- Peptides
- Polymerase acidic protein: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x MN: MANGANESE (II) ION(Non-covalent)
- 4 x KU0: 2-[(2S)-1-(3,5-dichloropyridine-4-carbonyl)pyrrolidin-2-yl]-5-hydroxy-6-oxo-N-[2-(phenylsulfonyl)ethyl]-1,6-dihydropyrimidine-4-carboxamide(Non-covalent)
- 4 x 9HD: 1-[(3R,5S,7R)-1,5,7,9-tetrakis(2-oxopyrrolidin-1-yl)nonan-3-yl]-1,3-dihydro-2H-pyrrol-2-one(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Beylkin, D. et al., Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus Endonuclease. Sci Rep (2017)
- Release Date
- 2018-02-07
- Peptides
- Polymerase acidic protein: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A